Jump to Main Content

2024 Highlights of ASH® in the Mediterranean

Highlights of ASH in the Mediterranean

Join the world's leading hematology experts at Highlights of ASH in the Mediterranean, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and non-malignant hematology.

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Through participation in this meeting, you will be able to:

  • Recap stand-out abstracts from the most recent ASH annual meeting.
  • Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field.
  • Participate in interactive panel discussions and attend small group lunch sessions with the experts.
  • Improve therapeutic and overall practice methods.
  • Discover new treatments for patients.

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

Program Co-Host

ASH is proud to co-host this meeting with the Emirates Society of Haematology.

Program Schedule

The following session topics corresponds to the 2024 Highlights of ASH in the Mediterranean and is subject to change.


8:00 a.m. Registration and Exhibits Open
8:15 a.m. Welcome, Introductions, and Announcements
8:30 a.m.

Special Education Session: Plasma Cell Dyscrasia Tumor Board

Mustaqeem Siddiqui, MD
Mayo Clinic International

Ahmad Al Huraiji, MD, MRCP
Kuwait Cancer Control Center

Shruti Prem Sudha, MD, DM
Bahrain Oncology Center

Rania Medhat Seliem, MD
Rashid Hospital DAHC

9:30 a.m.

Myeloma & Plasma Cell Dyscrasia

Surbhi Sidana, MD
Stanford University

10:00 a.m.

Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia

Jeanne Palmer, MD
Mayo Clinic

10:30 a.m.

Panel Discussion

11:00 a.m.

Coffee Break and Exhibits Open

11:30 p.m. Autoimmunity and Complement Disorders

Hanny Al-Samkari, MD
Harvard University

12:00 p.m.

Nosocomial Hematological Complications

Marie Scully, MD
University College London

12:30 p.m. Panel Discussion
1:00 p.m.

Lunch with the Experts Session (Ticketed Session)

2:00 p.m.

Special Education Session: Hemophilia in Europe, Middle East, and Africa

Tyler Buckner, MD
University of Colorado Denver

2:30 p.m. Inherited Bleeding Disorders

Angela Weyand, MD
University of Michigan

3:00 p.m. Panel Discussion
3:30 p.m. Coffee Break and Exhibits Open
4:00 p.m. Diagnosis, Management, and Treatment of VTE

Marc Carrier, MD
Ottawa Hospital

4:30 p.m. Hemoglobinopathies

Kevin Kuo, MD, MSc, FRCPC
University Health Network

5:00 p.m. Panel Discussion
5:30 p.m. Program Adjourns for the day
8:00 a.m. Registration and Exhibits Opens
8:15 a.m. Welcome and Introductions
8:30 a.m.

Transfusion Medicine: Blood Banking and Apheresis

Stella Chou, MD
The Children's Hospital

9:00 a.m.

Hematopoietic Stem Cell Transplantation

Betty Hamilton, MD
Cleveland Clinic

9:30 a.m. Panel Discussion
10:00 a.m. Coffee Break and Exhibition
10:30 a.m. Acute Lymphoblastic Leukemia

John Molina, MD, MEd
Cleveland Clinic

11:00 a.m. Acute Myeloid Leukemia

Alison Walker, MD
Mayo Clinic

11:30 a.m. Clonal Hematopoiesis and Myelodysplastic Syndromes

Valeria Santini, MD
University of Florence

12:00 p.m. Panel Discussion
12:30 p.m. Lunch with the Experts Session (Ticketed Session)
1:30 a.m.

Special Education Session: Lymphoma Tumor Board

Khalil al Farsi, MD
Sultan Qaboos University Hospital

Arif Alam, MBBS
Tawam Hospital

Ruba Taha, MBBS, MRCP
Hamad Medical Corporation

Rania Medhat Seliem, MD
Rashid Hospital DAHC

2:30 p.m. Coffee Break and Exhibition
3:00 p.m.

Low-Grade Lymphoma(Including Chronic Lymphoid Leukemia)

Joanna Meehan Rhodes, MD
Rutgers Cancer Institute

3:30 p.m.

High-Grade Lymphoma (Including CAR T-cell Therapy)

Manali Kamdar, MD
University of Colorado

4:00 p.m. Special Education Session: CAR T-Cell Therapy & Management of Its Toxicities

Oreofe Odejide, MD, MPH
Dana-Farber Cancer Institute

4:30 p.m. Panel Discussion
5:00 p.m. Closing Remarks and Adjournment

View Faculty Disclosure Information

The American Society of Hematology would like to acknowledge the following companies for the educational grants provided in support of the 2024 Highlights of ASH in the Mediterranean.

  • AstraZeneca
  • Pfizer, Inc.